Recursion to Participate in Upcoming Investor Conferences
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:
- SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:
Morgan Stanley Technology, Media and Telecom Conference – March 4-7, 2024
KeyBanc Emerging Technology Summit – March 5-6, 2024
Leerink Partners Global Biopharma Conference – March 11-13, 2024
KeyBanc Life Sciences & MedTech Investor Forum – March 19-20, 2024